Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability
about
Cutaneous Adverse Effects of Neurologic Medications.New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment.[Perampanel as a therapy option in patients with epilepsy].
P2860
Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Perampanel in the management o ...... acy, and patient acceptability
@ast
Perampanel in the management o ...... acy, and patient acceptability
@en
Perampanel in the management o ...... acy, and patient acceptability
@nl
type
label
Perampanel in the management o ...... acy, and patient acceptability
@ast
Perampanel in the management o ...... acy, and patient acceptability
@en
Perampanel in the management o ...... acy, and patient acceptability
@nl
prefLabel
Perampanel in the management o ...... acy, and patient acceptability
@ast
Perampanel in the management o ...... acy, and patient acceptability
@en
Perampanel in the management o ...... acy, and patient acceptability
@nl
P2860
P356
P1476
Perampanel in the management o ...... acy, and patient acceptability
@en
P2093
Mandy Hintz
P2860
P304
P356
10.2147/PPA.S63951
P407
P577
2015-01-01T00:00:00Z